Jasper Ridge Partners, L.P. Fate Therapeutics Inc Transaction History

Jasper Ridge Partners, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$17.78 - $42.39 $131,465 - $313,431	-7,394 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$47.84 - $64.34 $565,373 - $760,370	-11,818 Reduced 61.51%	7,394 $433,000
Q3 2021 Nov 12, 2021	BUY	$59.27 - $95.73 $919,574 - $1.49 Million	15,515 Added 419.66%	19,212 $1.14 Million
Q4 2020 Feb 12, 2021	BUY	$38.09 - $100.95 $140,818 - $373,212	3,697 New	3,697 $336,000

184

123M

15K

14K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $278M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Jasper Ridge Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Jasper Ridge Partners, L.P. with notifications on news.